DR. COLIN CLARK EDGERTON MD NPI 1245307578

NPI Information

  • NPI: 1245307578
  • Provider Name: DR. COLIN CLARK EDGERTON, MD
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2001 2ND AVE STE 201
    SUMMERVILLE, SC
    ZIP 29486
  • Phone: (843) 572-4840

Map and Directions

Get Directions

NPI Details

DR. Colin Clark Edgerton, MD is a rheumatology internal medicine in Summerville, SC with 24 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Colin Clark Edgerton, MD NPI is 1245307578. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2001

The provider's business location address is:

2001 2ND AVE STE 201
SUMMERVILLE, SC
ZIP 29486
Phone: (843) 572-4840
Fax: (843) 793-6156

The NPI 1245307578 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, belimumab, 10 mg (HCPCS:J0490)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, infliximab-abda, biosimilar, (renflexis), 10 mg (HCPCS:Q5104)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg (HCPCS:Q5103)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Complete ultrasound scan of joint (HCPCS:76881)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
  • Uric acid level, blood (HCPCS:84550)
  • Limited ultrasound scan of joint or other extremity structure lacking blood vessels (HCPCS:76882)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Rheumatoid factor level (HCPCS:86431)
  • X-ray of hand, 2 views (HCPCS:73120)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Tuberculosis test, gamma interferon (HCPCS:86480)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • X-ray of foot, 2 views (HCPCS:73620)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Measurement of dna antibody, single stranded (HCPCS:86226)
  • X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)

The enumeration date for this NPI number is 11/30/2006 and was last updated on 9/13/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatology22460NEBRASKANo
2207RR0500XInternal MedicineRheumatology35120SOUTH CAROLINAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.